4. Net investment income
In € thousand |
Property and casualty insurance |
Health insurance |
Life insurance |
Total |
||||
1–12/2018 |
1–12/2017 |
1–12/2018 |
1–12/2017 |
1–12/2018 |
1–12/2017 |
1–12/2018 |
1–12/2017 |
|
Investment property |
9,117 |
–2,910 |
5,783 |
15,647 |
32,475 |
40,932 |
47,375 |
53,670 |
Financial assets accounted for using the equity method |
58,565 |
8,396 |
19,553 |
16,133 |
31,071 |
25,662 |
109,189 |
50,190 |
Variable-income securities |
16,450 |
22,196 |
9,022 |
17,788 |
19,284 |
13,062 |
44,756 |
53,046 |
Available for sale |
14,807 |
22,196 |
8,902 |
16,597 |
19,194 |
23,048 |
42,903 |
61,841 |
At fair value through profit or loss |
1,642 |
0 |
120 |
1,191 |
90 |
–9,986 |
1,853 |
–8,795 |
Fixed-income securities |
77,511 |
82,293 |
83,104 |
54,203 |
253,456 |
229,231 |
414,071 |
365,727 |
Available for sale |
81,459 |
82,595 |
85,447 |
55,252 |
252,528 |
223,959 |
419,434 |
361,806 |
At fair value through profit or loss |
–3,948 |
–302 |
–2,343 |
–1,049 |
928 |
5,272 |
–5,363 |
3,921 |
Loans and other investments |
3,667 |
3,442 |
2,092 |
1,421 |
34,174 |
35,820 |
39,933 |
40,683 |
Loans |
450 |
2,210 |
1,754 |
2,695 |
10,142 |
7,735 |
12,345 |
12,640 |
Other investments |
3,217 |
1,232 |
339 |
–1,274 |
24,032 |
28,085 |
27,588 |
28,043 |
Derivative financial instruments |
–16,586 |
14,576 |
–10,485 |
20,647 |
–918 |
4,147 |
–27,989 |
39,370 |
Investment administration expenses, interest paid and other investment expenses |
–20,579 |
–8,245 |
–9,528 |
–9,472 |
–16,037 |
–12,834 |
–46,144 |
–30,551 |
Total |
128,145 |
119,747 |
99,541 |
116,368 |
353,505 |
336,019 |
581,191 |
572,134 |
|
|
|
|
|
|
|
|
|
Of which: |
|
|
|
|
|
|
|
|
Current income/expenses |
107,340 |
105,382 |
83,623 |
75,268 |
336,692 |
340,853 |
527,656 |
521,502 |
Gains/losses from disposals and changes in value |
20,805 |
14,366 |
15,917 |
41,100 |
16,813 |
–4,834 |
53,535 |
50,632 |
Impairments |
–13,062 |
–13,691 |
–1,280 |
–2,172 |
–15,650 |
–36,130 |
–29,992 |
–51,993 |
In € thousand |
Current income/ |
Gains/ |
Total |
of which impairment |
||||||
1–12/2018 |
1–12/2017 |
1–12/2018 |
1–12/2017 |
1–12/2018 |
1–12/2017 |
1–12/2018 |
1–12/2017 |
|||
|
||||||||||
Financial assets at fair value through profit or loss |
2,124 |
6,517 |
–33,624 |
27,979 |
–31,500 |
34,496 |
0 |
0 |
||
Variable-income securities (within the framework of fair value option) |
763 |
1,945 |
1,090 |
–10,740 |
1,853 |
–8,795 |
0 |
0 |
||
Fixed-income securities (within the framework of fair value option) |
1,510 |
4,002 |
–6,873 |
–81 |
–5,363 |
3,921 |
0 |
0 |
||
Derivative financial instruments |
–149 |
570 |
–27,841 |
38,800 |
–27,989 |
39,370 |
0 |
0 |
||
Investments under investment contracts1) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||
Available-for-sale financial assets |
392,045 |
383,100 |
70,292 |
40,547 |
462,337 |
423,647 |
–12,980 |
–38,964 |
||
Variable-income securities |
36,555 |
25,414 |
6,348 |
36,427 |
42,903 |
61,841 |
–10,175 |
–1,843 |
||
Fixed-income securities |
355,490 |
357,686 |
63,944 |
4,120 |
419,434 |
361,806 |
–2,805 |
–37,121 |
||
Loans and receivables |
39,116 |
42,006 |
817 |
–1,323 |
39,933 |
40,683 |
–89 |
0 |
||
Fixed-income securities |
7,921 |
8,362 |
1,272 |
800 |
9,193 |
9,162 |
0 |
0 |
||
Loans and other investments |
31,195 |
33,645 |
–455 |
–2,123 |
30,740 |
31,521 |
–89 |
0 |
||
Investment property |
78,781 |
70,241 |
–31,407 |
–16,571 |
47,375 |
53,670 |
–16,923 |
–13,029 |
||
Financial assets accounted for using the equity method |
61,733 |
50,190 |
47,456 |
0 |
109,189 |
50,190 |
0 |
0 |
||
|
|
|
|
|
|
|
|
|
||
Investment administration expenses, interest paid and other investment expenses |
–46,144 |
–30,551 |
0 |
0 |
–46,144 |
–30,551 |
0 |
0 |
||
Total |
527,656 |
521,502 |
53,535 |
50,632 |
581,191 |
572,134 |
–29,992 |
–51,993 |
||
In € thousand |
1–12/2018 |
1–12/2017 |
Current income/expenses from investment property |
|
|
Rent revenue |
110,491 |
109,449 |
Operational expenses |
–31,710 |
–39,208 |
Gains/losses from disposals and changes in value |
|
|
Currency gains/losses |
–16,603 |
–62,262 |
of which gains/losses from derivative financial instruments as part of US dollar underlying |
8,620 |
–68,199 |
of which gains/losses from derivative financial instruments as part of hedge transactions in US dollar |
–11,965 |
28,943 |
Positive currency effects from investments amounting to €9,558 thousand (2017: negative currency effects amounting to €–22,936 thousand) were recognised directly in equity.
In € thousand |
1–12/2018 |
1–12/2017 |
||
|
||||
Financial assets at fair value through profit or loss |
|
|
||
Recognised in profit/(loss) for the period |
–31,500 |
34,496 |
||
Available-for-sale financial assets |
|
|
||
Recognised in profit/(loss) for the period |
462,337 |
423,647 |
||
of which reclassified from equity to consolidated income statement |
–99,926 |
–130,195 |
||
Recognised in other comprehensive income1) |
–445,017 |
–148,323 |
||
Net income |
17,320 |
275,324 |
||
Loans and receivables |
|
|
||
Recognised in profit/(loss) for the period |
39,933 |
40,683 |
||
Financial liabilities measured at amortised cost |
|
|
||
Recognised in profit/(loss) for the period |
–52,800 |
–53,017 |
||